NovaBay Pharmaceuticals Inc Cash Flow-to-Debt Ratio
NovaBay Pharmaceuticals Inc cash flow-to-debt ratio. NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-2.27 Million could theoretically repay 0% of its total liabilities ($31.86 Million) in one year. Check NBY cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NovaBay Pharmaceuticals Inc (2005–2025)
Cash flow-to-debt ratio of NovaBay Pharmaceuticals Inc from 2005 to 2025. Historical debt coverage capacity for NovaBay Pharmaceuticals Inc across 21 annual periods. Check NovaBay Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
NovaBay Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2005–2025)
NovaBay Pharmaceuticals Inc cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for NovaBay Pharmaceuticals Inc. For the full cash flow conversion analysis, see NovaBay Pharmaceuticals Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $31.86 Million | ▲ +81.9% |
| 2024 | -1.46x | $-5.18 Million | $3.55 Million | ▼ -95.9% |
| 2023 | -0.74x | $-4.26 Million | $5.72 Million | ▲ +34.6% |
| 2022 | -1.14x | $-6.65 Million | $5.84 Million | ▼ -71.0% |
| 2021 | -0.67x | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.62x | $-4.72 Million | $2.92 Million | ▼ -108.9% |
| 2019 | -0.77x | $-7.93 Million | $10.25 Million | ▲ +38.8% |
| 2018 | -1.26x | $-5.57 Million | $4.41 Million | ▼ -50.8% |
| 2017 | -0.84x | $-6.27 Million | $7.49 Million | ▲ +42.8% |
| 2016 | -1.47x | $-12.13 Million | $8.28 Million | ▲ +19.6% |
| 2015 | -1.82x | $-18.56 Million | $10.18 Million | ▲ +31.1% |
| 2014 | -2.65x | $-15.05 Million | $5.69 Million | ▼ -45.6% |
| 2013 | -1.82x | $-12.97 Million | $7.13 Million | ▼ -44.4% |
| 2012 | -1.26x | $-6.53 Million | $5.19 Million | ▼ -165.2% |
| 2011 | -0.47x | $-3.14 Million | $6.62 Million | ▼ -217.6% |
| 2010 | 0.40x | $2.03 Million | $5.03 Million | ▲ +202.3% |
| 2009 | -0.39x | $-1.65 Million | $4.18 Million | ▲ +73.7% |
| 2008 | -1.50x | $-9.94 Million | $6.62 Million | ▼ -129.8% |
| 2007 | -0.65x | $-6.27 Million | $9.60 Million | ▼ -238.4% |
| 2006 | 0.47x | $4.74 Million | $10.05 Million | ▲ +104.5% |
| 2005 | -10.42x | $-3.23 Million | $310.00K | — |